STAT1 min. leídos
STAT+: Pharmalittle: Two Children Died After Getting Novartis Gene Therapy; Monkeypox Vaccine Maker Warns About Splitting Doses
Two children died from acute liver failure after receiving Zolgensma, a pricey Novartis gene therapy for a rare disease.
STAT1 min. leídos
STAT+: Pharmalittle: Judge Rules Walgreens Helped Fuel San Francisco Opioid Crisis; U.S. Plan To Bottle Monkeypox Vaccine Could Take Months
A U.S. federal judge ruled that Walgreens helped fuel the opioid epidemic in San Francisco by shipping thousands of “suspicious orders” of prescription drugs to its pharmacies.
STAT1 min. leídos
STAT+: Pharmalittle: Endo Bankruptcy Filing Over Opioid Crisis Appears Imminent; U.S. To Allow Fractional Doses Of Monkeypox Vaccine
Endo International, facing thousands of lawsuits alleging it fueled the opioid addiction crisis, said it is likely to file for bankruptcy imminently.
STAT1 min. leídos
STAT+: Pharmalittle: Pfizer To Test A Lyme Disease Vaccine; Only Monkeypox Drug In The U.S. Is Hard To Access
Pfizer and Valneva have begun a late-stage trial of a Lyme disease vaccine as the tick-borne illness is rapidly spreading across the U.S. and Europe.
STAT1 min. leídos
STAT+: Pharmalittle: Medicare Is Poised To Negotiate Drug Prices; Pfizer To Pay $5.4 Billion For Global Blood Therapeutics
Soon, Medicare will be able to use the full brunt of its leverage to negotiate discounts from drugmakers, like the governments in many other high-income countries.
STAT1 min. leídos
STAT+: Pharmalittle: PhRMA Threatens Dems If Drug-pricing Bill Passes; Novo Plays Down Worries Over Obesity Drug Supplies
PhRMA wrote members of Congress urging them to vote against the reconciliation package and is threatening to "hold them accountable."
STAT1 min. leídos
STAT+: Pharmalittle: U.S. Government Blunder Contributed To Monkeypox Vax Shortage; Amgen To Pay $4 Billion For ChemoCentryx
Amgen will acquire ChemoCentryx for $4 billion to obtain a newly approved medicine that treats patients with a serious autoimmune condition.
STAT1 min. leídos
STAT+: Pharmalittle: AbbVie Wins Court Opinion On Humira Patent Thickets; Alnylam Heart Disease Drug Succeeds In Closely Watched Trial
A U.S. appeals court panel declined to revive a lawsuit that accused AbbVie of using a so-called patent thicket to forestall competition for Humira.
STAT1 min. leídos
STAT+: Pharmalittle: West Virginia Cities Reach Deal With Wholesalers Over Opioid Crisis; Democrats’ Economic Plan Would Raises Taxes On Pharma
West Virginia cities and counties reached a $400 million settlement with three wholesalers over allegations they fueled an opioid crisis in the state.
STAT1 min. leídos
STAT+: Pharmalittle: Global Demand For Monkeypox Vaccine Will Be Hard To Meet; Amgen Dispute With IRS Heats Up
Amgen is in a heated fight with the U.S. Internal Revenue Service over its international tax strategy and $10.7 billion in back taxes and penalties the agency says it is…
STAT1 min. leídos
STAT+: Pharmalittle: Pharma Wages ‘Hail Mary’ Campaign To Sink Reconciliation Bill; Moderna Inks $1.74 Billion Deal With U.S. For Omicron Shot
Drugmakers are waging an intense lobbying campaign in a last-minute attempt to bring down the revived budget reconciliation bill pushed by Democrats.
STAT1 min. leídos
STAT+: Pharmalittle: Teva Reaches $4.25 Billion Deal Over Its Role In Opioid Crisis; Feds Probe Cassava Over Alzheimer’s Drug Data
Teva Pharmaceutical reached a national settlement worth up to $4.25 billion to resolve thousands of lawsuits over its alleged role in the opioid crisis.
STAT1 min. leídos
STAT+: Pharmalittle: FDA Will Review Biogen ALS Drug Despite Inconclusive Results; Shkreli Launches Drug-discovery Software Company
The FDA agreed to review a Biogen treatment for a rare, genetically defined form of ALS, even though a clinical trial failed to show a definitive benefit.
STAT1 min. leídos
STAT+: Pharmalittle: White House To Launch Effort For New Generation Of Covid Shots; Indian Court Rejects Bail Pleas In Biocon Bribery Case
The Biden administration is preparing a sweeping initiative to develop a next generation of Covid-19 immunizations that would thwart future coronavirus variants.
STAT1 min. leídos
STAT+: Pharmalittle: Congress May Miss Deadline To Pass FDA User-fee Bill; ViiV Is Urged To Lower Price For Its HIV Prevention Drug
With just over two month to go, it appears increasingly likely that Congress is going to miss its deadlines to pass a final FDA appropriations bill and a user-fee reauthorization.
STAT1 min. leídos
STAT+: Pharmalittle: Roche CEO To Step Down Next Year; Gates Foundation Withdraws Financial Support For Malaria Vaccine
Roche chief executive Severin Schwan will step down next March and has been nominated as chair, after 15 years at the helm.
STAT1 min. leídos
STAT+: Pharmalittle: FDA User-fee Reauthorization Bill Hits A Snag; USPTO Takes A Tougher Stand Toward Drugmakers
People who work at biotechs, life sciences firms, and drugmakers pull in the largest salaries of anyone in health care — usually more than $100,000 per year.
STAT1 min. leídos
STAT+: Pharmalittle: Biotech CEOs Pull In Some Of Health Care’s Biggest Paydays; Split Emerges Between Groups Providing Abortion Pills
When it comes to executive compensation in the biotech and pharma sectors, it pays to be the CEO at Regeneron Pharmaceuticals.
STAT1 min. leídos
STAT+: Pharmalittle: Will The Supreme Court Review Controversial Patent Rulings? GSK Prepares For Its Consumer Health Spinoff
In the coming weeks, the U.S. Supreme Court is expected to decide whether to review a debate over patents that has the pharmaceutical industry on edge.
STAT1 min. leídos
STAT+: Pharmalittle: Teva Asks U.S. Supreme Court To Review Skinny Labeling; European Commission Rebuked For Pfizer Texts
Teva Pharmaceuticals is taking a long-running battle over generic drug labeling to the U.S. Supreme Court.
STAT1 min. leídos
STAT+: Pharmalittle: Covid Worsened Antibiotic Resistance; Teva And AbbVie Unit Settle Opioid Suit With San Francisco
Resistance to medicines for combating superbugs has worsened during the pandemic, with deaths and infections from several pathogens increasing at least 15%.
STAT1 min. leídos
STAT+: Pharmalittle: N.Y. AG Claims Teva Lied About Its Role In The Opioid Crisis; Doctors Question Compounded Versions Of Novo Weight Loss Drug
The New York attorney general argued that Teva Pharmaceutical lied to evade accountability for helping fuel the opioid crisis.
STAT1 min. leídosDiscrimination & Race Relations
STAT+: Pharmalittle: Perrigo Seeks FDA Approval To Sell Birth Control Over The Counter; 1.1 Billion Covid Vaccines Have Been Wasted
Perrigo has applied to the FDA for approval of what would be the first daily birth control pill available over-the-counter in the U.S.
STAT1 min. leídosAmerican Government
STAT+: Pharmalittle: Senate Dems Vet A Tweaked Version Of Drug-pricing Bill; Biotechs Double Down On Developing Birth Control Products
Senate Democrats are vetting a new, tweaked version of a prescription-drug pricing package as they hurtle toward a September deadline to pass major reforms.
STAT1 min. leídosGender Studies
STAT+: Pharmalittle: Pfizer And U.S. Strike $3.2 Billion Deal For Covid Vaccine; Marketing Of Morning-after Pills Shifts To Mail-order Options
Companies that sell sexual health products and medicines online are shifting their marketing to highlight mail-order emergency contraception.
STAT1 min. leídos
STAT+: Pharmalittle: Retailers Ration Contraceptive Pills As Demand Spikes; Supreme Court Rules Doctors Must Knowingly Misprescribe Opioids To Be Convicted
Some big retailers are rationing over-the-counter emergency contraceptive pills as demand spikes following the U.S. Supreme Court ruling on abortion.
STAT1 min. leídosGender Studies
STAT+: Pharmalittle: Abortion Pills Will Be At Center Of Legal Battles; Gilead Reaches $33 Million Settlement Over Patient Assistance Programs
Abortion pills, already used in more than half of abortions in the U.S., are becoming even more sought-after in the aftermath of Roe v. Wade being overturned.
STAT1 min. leídos
STAT+: Pharmalittle: Sarepta Halts A Duchenne Clinical Trial Over Safety; Why The CVS Health Whistleblower Lawsuit Comes At A Pivotal Moment
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT1 min. leídos
STAT+: Pharmalittle: Senate Bill Would Allow Insulin Makers To Lock In Profits; GSK, Novartis Pledge Funds For Diseases That Mostly Affect The Poor
CVS Caremark will return the Eliquis blood thinner to its formulary, reversing a decision that sparked protests from physicians and patients.
STAT1 min. leídos
STAT+: Pharmalittle: U.K. Inks $1.2 Billion Deal With Moderna For Vaccine Center; Top Biocon Exec Arrested In Bribery Scandal
Enanta Pharmaceuticals filed a lawsuit alleging the Pfizer Covid-19 pill violates a patent for its own Covid drug still in development.
… o descubre algo nuevo